Multiple Sclerosis

Posted by Optivida Health on

Multiple sclerosis (MS) is an autoimmune disorder that attacks the myelin sheath covering nerves.

Symptoms vary in severity based on the amount and location of nerve damage. Symptoms include tremor, lack of coordination, unsteady gait, tingling or pain in body parts, numbness or weakness in one or more limbs, partial or complete loss of vision in one or both eyes, double vision or blurred vision, slurred speech, fatigue, dizziness and heat sensitivity.

Start Shopping Now!

Hemp Extract impacts MS via several mechanisms. It decreases the autoimmune inflammatory destruction of the myelin sheath. Hemp Extract modulates the immune response, halting the assault on the central nervous system. This helps to slow or even stop the progression of MS and decreases the associated symptoms of pain and muscle stiffness.

Hemp Extract also improves serotonin levels in the brain, improving sleep and depressed mood, both common issues with MS patients.

Oral Hemp Extract can be used daily along with topical Hemp Extract, which is applied to tight or painful muscle areas.


Thank you for taking your time to become educated on the science and technologies behind the best health supplements.

Start Shopping Now

My best wishes for your best health.

Frank Davis,
Founder and CEO of Optivida Health

[For more science-based evidence for the use of hemp extract read "Hemp Health Revolution: The A to Z Health Benefits of Hemp Extract"] 


*Neurobiol Dis. 2013 Nov;59:141-50. doi: 10.1016/j.nbd.2013.06.016. Epub 2013 Jul 11.
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptor.

*Curr Med Res Opin. 2007 Jan;23(1):17-24.
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

*Fitoterapia. 2017 Jan;116:77-84. doi: 10.1016/j.fitote.2016.11.010. Epub 2016 Nov 25.
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.

*Eur Neurol. 2016;76(5-6):216-226. Epub 2016 Oct 13. Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice. CNS Neurol Disord Drug Targets. 2017;16(5):541-553. doi: 10.2174/1871527316666170413114210.

Neurological Aspects of Medical Use of Cannabidiol.


← Older Post Newer Post →